Alx Other Liab vs Capital Stock Analysis
ALXO Stock | USD 10.63 0.02 0.19% |
Alx Oncology financial indicator trend analysis is way more than just evaluating Alx Oncology Holdings prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alx Oncology Holdings is a good investment. Please check the relationship between Alx Oncology Other Liab and its Capital Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Other Liab vs Capital Stock
Other Liab vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alx Oncology Holdings Other Liab account and Capital Stock. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Alx Oncology's Other Liab and Capital Stock is -0.22. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Alx Oncology Holdings, assuming nothing else is changed. The correlation between historical values of Alx Oncology's Other Liab and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Alx Oncology Holdings are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Other Liab i.e., Alx Oncology's Other Liab and Capital Stock go up and down completely randomly.
Correlation Coefficient | -0.22 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Other Liab
Capital Stock
The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.Most indicators from Alx Oncology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alx Oncology Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. At this time, Alx Oncology's Issuance Of Capital Stock is very stable compared to the past year. As of the 31st of May 2024, Sales General And Administrative To Revenue is likely to grow to 11.84, while Tax Provision is likely to drop 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 83.6M | 127.4M | 169.4M | 177.9M | Cost Of Revenue | 736K | 1.5M | 836K | 1.4M |
Alx Oncology fundamental ratios Correlations
Click cells to compare fundamentals
Alx Oncology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alx Oncology fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 10.7M | 436.1M | 380.2M | 306.5M | 242.6M | 254.3M | |
Other Current Liab | 1.2M | 6.2M | 257K | 19.2M | 25.8M | 27.1M | |
Total Current Liabilities | 5.0M | 6.2M | 15.3M | 28.3M | 36.0M | 37.8M | |
Total Stockholder Equity | (276K) | (118.5M) | (202.0M) | (325.5M) | 189.7M | 199.2M | |
Other Liab | 547K | 5K | 1.8M | 53K | 61.0K | 57.9K | |
Net Tangible Assets | (70.6M) | 429.8M | 363.0M | 263.5M | 303.0M | 205.5M | |
Property Plant And Equipment Net | 860K | 52K | 3.5M | 9.8M | 10.8M | 11.4M | |
Net Debt | (3.6M) | (434.2M) | (362.9M) | (272.5M) | (5.2M) | (5.5M) | |
Retained Earnings | (72.8M) | (118.5M) | (202.0M) | (325.5M) | (486.3M) | (462.0M) | |
Accounts Payable | 3.7M | 4K | 3.8M | 8.1M | 8.6M | 4.6M | |
Cash | 9.0M | 434.2M | 363.7M | 282.9M | 22.4M | 21.3M | |
Non Current Assets Total | 867K | 1.8M | 13.2M | 35.5M | 53.9M | 56.6M | |
Cash And Short Term Investments | 9.0M | 434.2M | 363.7M | 282.9M | 182.7M | 234.8M | |
Common Stock Shares Outstanding | 36.5M | 39.8M | 40.3M | 40.7M | 43.0M | 40.8M | |
Liabilities And Stockholders Equity | 10.7M | 436.1M | (184.9M) | (282.4M) | 242.6M | 254.7M | |
Non Current Liabilities Total | 6.0M | 5K | 1.8M | 14.7M | 16.8M | 17.7M | |
Capital Surpluse | 2.1M | 548.3M | 565.0M | 589.7M | 678.2M | 375.5M | |
Other Current Assets | 256K | 1.8M | 3.4M | 4.8M | 4.9M | 2.9M | |
Other Stockholder Equity | 2.1M | 118.5M | (41K) | 804K | 675.7M | 709.5M | |
Total Liab | 11.0M | 436.1M | 17.1M | 43.0M | 52.8M | 74.9M | |
Net Invested Capital | (65.2M) | 429.8M | 363.0M | 272.9M | 199.4M | 210.5M | |
Property Plant And Equipment Gross | 860K | 52K | 3.5M | 10.2M | 12.1M | 12.7M | |
Total Current Assets | 9.8M | 434.2M | 367.0M | 271.0M | 188.7M | 234.8M | |
Accumulated Other Comprehensive Income | (1.4M) | (554.6M) | 0.0 | (845K) | 256K | 268.8K | |
Net Working Capital | 4.8M | 429.8M | 351.7M | 242.6M | 152.7M | 218.2M | |
Property Plant Equipment | 860K | 52K | 897K | 3.9M | 4.5M | 4.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Alx Stock analysis
When running Alx Oncology's price analysis, check to measure Alx Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alx Oncology is operating at the current time. Most of Alx Oncology's value examination focuses on studying past and present price action to predict the probability of Alx Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alx Oncology's price. Additionally, you may evaluate how the addition of Alx Oncology to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Alx Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.45) | Return On Equity (0.82) |
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.